MARKET

CASI

CASI

CASI Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.960
0.000
0.00%
Opening 11:06 01/29 EST
OPEN
2.960
PREV CLOSE
2.960
HIGH
3.000
LOW
2.950
VOLUME
31.91K
TURNOVER
--
52 WEEK HIGH
3.830
52 WEEK LOW
2.830
MARKET CAP
235.74M
P/E (TTM)
-6.6682
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CASI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CASI News

  • What You Must Know About CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Beta Value
  • Simply Wall St..3d ago
  • Have Insiders Been Buying CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Shares?
  • Simply Wall St..12/20/2019 10:27
  • Week In Review: Alphamab Oncology Plans $350 Million Hong Kong IPO
  • Seeking Alpha - Article.12/08/2019 19:06
  • CASI Pharma's CD19 CAR-T clinical trial applications OK'd in China
  • Seeking Alpha - Article.12/04/2019 11:49

More

Industry

Biotechnology & Medical Research
+0.09%
Pharmaceuticals & Medical Research
+0.41%

Hot Stocks

Name
Price
%Change

About CASI

CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of therapeutics for cancer and other medical needs. It operates through the development of targeted therapeutics for the treatment of cancer segment. Its product pipeline includes internal development of its lead drug candidate, ENMD-2076; MARQIBO, ZEVALIN and EVOMELA, and early-stage candidates in preclinical development. Its ENMD-2076 is an orally active, Aurora A/angiogenic kinase inhibitor with a kinase selectivity profile and multiple mechanisms of action. Its Marqibo is a sphingomyelin/cholesterol liposome-encapsulated, formulation of vincristine sulfate. Its ZEVALIN (ibritumomab tiuxetan) injection for intravenous use is a CD20-directed radiotherapeutic antibody. Its EVOMELA is an intravenous formulation of melphalan being investigated by Spectrum in the multiple myeloma transplant setting. Its pipeline also includes 2ME2 (2-methoxyestradial).
More

Webull offers CASI Pharmaceuticals Inc (CASI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.